Pancreatic Cancer Clinical Trial Patient Recruitment

Pancreatic cancer patient recruitment for resectable, locally advanced, and metastatic clinical trials.

Who qualifies: Adults with pancreatic ductal adenocarcinoma (PDAC) across all stages, including KRAS and BRCA mutation carriers.

Recruitment challenges: Rapid disease progression and performance status decline require fast enrollment.

Our approach: GI oncology and surgical oncology referral networks with expedited pre-screening protocols.